1. Home
  2. RAC vs VOR Comparison

RAC vs VOR Comparison

Compare RAC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAC
  • VOR
  • Stock Information
  • Founded
  • RAC 2024
  • VOR 2015
  • Country
  • RAC United States
  • VOR United States
  • Employees
  • RAC N/A
  • VOR N/A
  • Industry
  • RAC
  • VOR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAC
  • VOR Health Care
  • Exchange
  • RAC Nasdaq
  • VOR Nasdaq
  • Market Cap
  • RAC 302.3M
  • VOR 261.0M
  • IPO Year
  • RAC 2025
  • VOR 2021
  • Fundamental
  • Price
  • RAC $10.20
  • VOR $1.60
  • Analyst Decision
  • RAC
  • VOR Buy
  • Analyst Count
  • RAC 0
  • VOR 6
  • Target Price
  • RAC N/A
  • VOR $3.90
  • AVG Volume (30 Days)
  • RAC 99.0K
  • VOR 4.3M
  • Earning Date
  • RAC 01-01-0001
  • VOR 11-06-2025
  • Dividend Yield
  • RAC N/A
  • VOR N/A
  • EPS Growth
  • RAC N/A
  • VOR N/A
  • EPS
  • RAC N/A
  • VOR N/A
  • Revenue
  • RAC N/A
  • VOR N/A
  • Revenue This Year
  • RAC N/A
  • VOR N/A
  • Revenue Next Year
  • RAC N/A
  • VOR N/A
  • P/E Ratio
  • RAC N/A
  • VOR N/A
  • Revenue Growth
  • RAC N/A
  • VOR N/A
  • 52 Week Low
  • RAC $9.87
  • VOR $0.13
  • 52 Week High
  • RAC $10.34
  • VOR $3.29
  • Technical
  • Relative Strength Index (RSI)
  • RAC N/A
  • VOR 34.25
  • Support Level
  • RAC N/A
  • VOR $1.80
  • Resistance Level
  • RAC N/A
  • VOR $2.03
  • Average True Range (ATR)
  • RAC 0.00
  • VOR 0.13
  • MACD
  • RAC 0.00
  • VOR -0.05
  • Stochastic Oscillator
  • RAC 0.00
  • VOR 5.69

About RAC Rithm Acquisition Corp. Class A Ordinary Shares

Rithm Acquisition Corp is a blank check company.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: